Physician profile
David Holler
NPI 1184672859
$76,495.99
in general payments reported to CMS, 2019-2025
18 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $328 · 2021: $12K · 2022: $11K · 2023: $19K · 2024: $18K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $6,896 · Food and Beverage: $5,225 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,090 · Entertainment: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,169.01 |
| Travel and Lodging | $6,896.00 |
| Food and Beverage | $5,225.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,090.00 |
| Entertainment | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $50,172.48 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Coopervision INC. | $22,791.50 | 2019-2025 | Misight Contact Lens, Synergeyes Contact Lens, Cvi Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,295.47 | 2020-2025 | Acuvue |
| Alcon Vision LLC | $1,006.91 | 2019-2025 | Precision 1, Tryptyr, Hydrus Microstent |
| Maculogix, INC. | $189.37 | 2019 | |
| Optos, INC. | $187.58 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $148.70 | 2025 | Xdemvy |
| Allergan, INC. | $121.69 | 2022 | |
| Novartis Pharmaceuticals Corporation | $115.44 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $89.22 | 2022-2024 | Miebo, Zenlens |
| Notal Vision, INC. | $81.19 | 2025 | Foresee Home |
| Shire North American Group INC | $65.96 | 2019 | |
| Topcon Healthcare, INC. | $62.92 | 2023 | |
| Sun Pharmaceutical Industries INC. | $61.78 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $58.09 | 2019-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $22.76 | 2019 | |
| Carl Zeiss Meditec, INC. | $12.59 | 2019 | |
| Abbvie INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Holler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.